Artal Group S.A. Adaptive Biotechnologies Corp Transaction History

Artal Group S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$45.01 - $65.47 $4.5 Million - $6.55 Million	-100,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$35.79 - $48.81 $3.15 Million - $4.3 Million	-88,000 Reduced 46.81%	100,000 $4.86 Million
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $299,400 - $580,560	-12,000 Reduced 6.0%	188,000 $9.1 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $848,000 - $1.71 Million	50,000 Added 33.33%	200,000 $5.56 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $1.52 Million - $2.68 Million	-50,000 Reduced 25.0%	150,000 $4.64 Million
Q2 2019 Aug 09, 2019	BUY	$40.3 - $48.3 $8.06 Million - $9.66 Million	200,000 New	200,000 $9.66 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.